Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effects of D-Fagomine on Glycaemic Response to Sucrose in Men

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01528631
Recruitment Status : Completed
First Posted : February 8, 2012
Last Update Posted : July 25, 2012
Sponsor:
Collaborators:
University Rovira i Virgili
Technological Centre of Nutrition and Health
National Research Council, Spain
Information provided by (Responsible Party):
Bioglane

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The aim of this study is to evaluate the effect of D-fagomine on glycaemic response to sucrose in men.

Condition or disease Intervention/treatment Phase
Glycaemic Response Insulinemic Response Other: D-Fagomine Not Applicable

Detailed Description:
To determine and compare glycaemic response to sucrose of D-Fagomine and control in the timeframe of 180 minutes.

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 12 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Basic Science
Official Title: Randomized Controlled Double-blind Nutritional Intervention Trial to Evaluate the Effects of D-fagomine on Glycaemic Response to Sucrose in Men
Study Start Date : February 2012
Actual Primary Completion Date : May 2012
Actual Study Completion Date : June 2012

Resource links provided by the National Library of Medicine

Drug Information available for: Sucrose

Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Placebo Comparator: Control Product
200 ml water with 50g of sucrose
 Other: D-Fagomine
0 mg (control) blended with 50 grams of sucrose in 200 ml of water.
Active Comparator: Product 1
200 ml water with 50g of sucrose and supplemented with 30 mg of D-Fagomine
 Other: D-Fagomine
30 mg (initial dose), with 50 grams of sucrose in 200 ml of water.


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Glycaemic response to sucrose [ Time Frame: 0-180 minutes ]

Secondary Outcome Measures :
  1. Insulin in venous plasma [ Time Frame: 0-180 minutes ]

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

1. Males between the ages of 20 and 70 willing and able to provide written informed consent.

Exclusion Criteria:

  1. LDL cholesterol levels higher than 189 mg/dl
  2. Triglycerides higher than 350 mg/dl (the threshold level to determine c-LDL using the Friedewald formula)
  3. Physical examinations and routine biochemical analysis shall be conducted to rule out pathologies.
  4. Consumption of supplements or acetylsalicylic acid
  5. Chronic alcoholism
  6. Body mass index (BMI) greater than 30 kg/m2
  7. Previous antihypertensive treatment at the start of the trial that has not finished at least 2 months before beginning the study
  8. Diabetes mellitus (if the fasting blood glucose is higher than 126 mg/dl, the test should be repeated and confirmed)
  9. Kidney disease (serum creatine levels above 1,4 mg/dl for women and above 1,5 mg/dl for men)
  10. Acute infectious diseases, malignant tumors, severe liver failure, respiratory failure associated with chronic or endocrine diseases
  11. Other conditions such as special dietary needs
  12. To be participating or having participated in a clinical trial within the last 3 months
  13. Inability to continue the study
  14. History of gastrointestinal disease which may alter the absorption of nutrients
  15. Depressive disorder or thoughts of self-injury
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01528631


Locations
Layout table for location information
Spain
Hospital Universitari Sant Joan, Universitat Rovira i Virgili
Reus, Tarragona, Spain, 43204
Sponsors and Collaborators
Bioglane
University Rovira i Virgili
Technological Centre of Nutrition and Health
National Research Council, Spain
Investigators
Layout table for investigator information
Principal Investigator: Rosa Solà, PhD MD University Rovira i Virgili
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Additional Information:
BIOGLANE SLNE  This link exits the ClinicalTrials.gov site D-Fagomine  This link exits the ClinicalTrials.gov site CTNS - Technology Centre of Nutrition and Health  This link exits the ClinicalTrials.gov site URV - Rovira i Virgili University  This link exits the ClinicalTrials.gov site

Publications:

Layout table for additonal information
Responsible Party: Bioglane
ClinicalTrials.gov Identifier: NCT01528631     History of Changes
Other Study ID Numbers: 1AP029010911
First Posted: February 8, 2012    Key Record Dates
Last Update Posted: July 25, 2012
Last Verified: July 2012